mRNA Injury Series - Erythema Multiforme after Pfizer and Moderna COVID-19 mRNA Vaccines - 14 papers reviewed with photographs of 20 confirmed cases - mRNA Injury to the Immune system

Australian Government added Erythema Multiforme on its COVID-19 Vaccine Claims Scheme on April 3, 2023

Papers Reviewed:

• 2023 Jun (Murata et al) - Erythema Multiforme Induced by Zonisamide and Triggered by the First Dose of COVID-19 Vaccine (Pfizer-BioNTech)

• 2023 Apr (Yousefian et al) - Occurrence of erythema multiforme following COVID-19 vaccination: a review

• 2023 Feb (Karatas et al) - Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series

• 2022 Nov (Fadul et al) - Sever erythema multiforme post-COVID-19 moderna vaccine: Case report and literature review

• 2022 Apr (Castillo et al) - Erythema multiforme after the third dose of mRNA-1273 (behind paywall)

• 2022 Mar (Petruzzi et al) - Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases

• 2021 Nov (Burlando et al) - Cutaneous reactions to COVID-19 vaccine at the dermatology primary care

• 2021 Oct (Kim et al) - Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech)

• 2021 Oct (Wunderlich et al) - Erythema exsudativum multiforme infolge einer COVID-19-Impfung (BNT162b2)

• 2021 Oct (Saibene et al) - Erythema Multiforme Major following SARS-CoV-2 vaccine

• 2021 Oct (Majenka et al) - Multiforme Erytheme nach COVID-19-mRNA-Impfung

• 2021 Sep (Bonino et al) - Atypical erythema multiforme related to BNT162b2 (Pfizer–BioNTech) COVID‐19 vaccine

• 2021 Sep (Borg et al) - Pfizer-BioNTech SARS-CoV-2 mRNA vaccine-associated erythema multiforme

• 2021 Sep (Scharf et al) - Nevocentric erythema multiforme after SARS‐COV‐2 vaccine